To investigate the impact of EZH2 expression on the immune infiltration landscape of pan-cancer, the link between EZH2 expression and infiltration levels of six tumor-infiltrating immune cells (CD4 + T cells, CD8 + T cells, B cells, macrophages, DC, and neutrophils) was assessed based on the TIMER algorithm. The gene discussed is EZH2; the disease is cancer.